AM

Arvind Makhan Lal Shah

Active Director Director DIN 01306408
DIN 01306408 First appointment Apr 2007 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Apr 2007
Shareholding value •••• Premium profile

About Arvind Makhan Lal Shah

Data last updated:

Arvind Makhan Lal Shah is a Director at Accura Inks Private Limited (since 2016) and Director at Sampannata Health And Foods Private Limited (since 2018). The companies operate in Chemicals and Materials, Pharma and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹56.38 Cr; the largest is Accura Inks Private Limited at ₹55.29 Cr (FY 2025). Earlier, Arvind Makhan Lal Shah was a Director at Ocsky Advisors Private Limited (2011–2014) and Director at S-Square Procon Private Limited (2010–2016) and 2 more.

DIN 01306408
Primary Designation Director
Industry Chemicals and Materials
First Appointment 20 Apr 2007
Oldest Company Age 19 yrs
Largest company Accura Inks Private Limited · ₹55.29 Cr (FY 2025)
Combined revenue ₹56.38 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Accura Inks Private Limited U74110GJ2014PTC080377
Director30 Aug 20162014₹55.29 Cr (FY 2025)Active
Director13 Mar 20182018₹1.09 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ocsky Advisors Private Limited U74140GJ2011PTC068236
Director15 Dec 20112011₹18.6 Lakh (FY 2024)Active
S-Square Procon Private Limited U45201GJ2009PTC058023
Director26 Aug 20102009Strike Off
Madoc Commercials Private Limited U01111GJ2007PTC050602
Director20 Apr 20072007Amalgamated
Director23 Apr 20072007Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Arvind Makhan Lal Shah

Directorship timeline

Open interactive timeline →
Madoc Commercials Private Limited
Accura Inks Private Limited
Arham Metals & Commodities Private Limited
Sampannata Health And Foods Private Limited
Premium access

Shareholding and investment profile for Arvind Makhan Lal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Makhan Lal Shah

Arvind Makhan Lal Shah currently holds 2 directorships: Accura Inks Private Limited (Director, since 30 Aug 2016, revenue ₹55.29 Cr (FY 2025)); Sampannata Health And Foods Private Limited (Director, since 13 Mar 2018, revenue ₹1.09 Cr (FY 2025)).

Arvind Makhan Lal Shah was first appointed on 20 Apr 2007 as Director at Madoc Commercials Private Limited. The most recent appointment on record is 13 Mar 2018 at Sampannata Health And Foods Private Limited.

The 2 current companies of Arvind Makhan Lal Shah that report revenue have a combined latest revenue of ₹56.38 Cr: Accura Inks Private Limited ₹55.29 Cr (FY 2025); Sampannata Health And Foods Private Limited ₹1.09 Cr (FY 2025).

Arvind Makhan Lal Shah held 4 earlier board appointments: Ocsky Advisors Private Limited (Director, 15 Dec 2011 to 15 Dec 2014); S-Square Procon Private Limited (Director, 26 Aug 2010 to 19 Aug 2016); Madoc Commercials Private Limited (Director, from 20 Apr 2007); Arham Metals & Commodities Private Limited (Director, from 23 Apr 2007).

The current boards of Arvind Makhan Lal Shah's companies include Rishav Saket Kanoria (Accura Inks Private Limited), Vivek Ramesh Dave (Accura Inks Private Limited), Harish Venkappa Anchan (Sampannata Health And Foods Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available